Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

A benefit-cost analysis of two-dose measles immunization in Canada.

Pelletier L, Chung P, Duclos P, Manga P, Scott J.

Vaccine. 1998 May-Jun;16(9-10):989-96.

PMID:
9682349
3.

Mumps and rubella consensus conference.

[No authors listed]

Can Commun Dis Rep. 1994 Oct 15;20(19):165-76. Review. English, French. No abstract available.

PMID:
7804152
4.

Measles control in the United States: problems of the past and challenges for the future.

Wood DL, Brunell PA.

Clin Microbiol Rev. 1995 Apr;8(2):260-7. Review.

5.

Measles control in developing and developed countries: the case for a two-dose policy.

Tulchinsky TH, Ginsberg GM, Abed Y, Angeles MT, Akukwe C, Bonn J.

Bull World Health Organ. 1993;71(1):93-103. Review.

6.

A combination vaccine against measles, mumps, rubella and varicella.

Knuf M, Faber J, Barth I, Habermehl P.

Drugs Today (Barc). 2008 Apr;44(4):279-92. Review.

PMID:
18536786
7.

Two dose MMR vaccine schedule.

Burgess MA.

J Paediatr Child Health. 1994 Oct;30(5):453. Review. No abstract available.

PMID:
7833088
8.

Consensus conference on measles.

[No authors listed]

Can Commun Dis Rep. 1993 May 30;19(10):72-9. Review. English, French. No abstract available.

PMID:
8348101
9.

A new combination vaccine for measles, mumps, rubella and varicella.

Zareba G.

Drugs Today (Barc). 2006 May;42(5):321-9. Review.

PMID:
16801995
10.

Two-dose measles vaccination schedules.

Rosenthal SR, Clements CJ.

Bull World Health Organ. 1993;71(3-4):421-8. Review.

11.

Targeting rubella for elimination.

Taneja DK, Sharma P.

Indian J Public Health. 2012 Oct-Dec;56(4):269-72. doi: 10.4103/0019-557X.106413. Review.

12.

Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience.

Morice A, Carvajal X, León M, Machado V, Badilla X, Reef S, Lievano F, Depetris A, Castillo-Solórzano C.

J Infect Dis. 2003 May 15;187 Suppl 1:S158-63. Review.

PMID:
12721908
13.

Varicella vaccines and measles, mumps, rubella, and varicella vaccine.

Bricks LF, Sato HK, Oselka GW.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S101-8. Review.

14.

[Issues related to rubella, measles and epidemic parotiditis in the Russian Federation].

Zverev VV, Iuminova NV.

Vopr Virusol. 2004 May-Jun;49(3):8-11. Review. Russian.

PMID:
15188648
15.

[Vaccination calendar and new risks of infection].

Bégué P.

Ann Med Interne (Paris). 1998 Oct;149(6):379-84. Review. French.

PMID:
9853048
16.

[Effectiveness, population-level effects, and heath economics of measles and rubella vaccination].

Wichmann O, Ultsch B.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Sep;56(9):1260-9. doi: 10.1007/s00103-013-1801-7. Review. German.

PMID:
23990088
17.

Measles and rubella in the World Health Organization European region: diversity creates challenges.

Spika JS, Wassilak S, Pebody R, Lipskaya G, Deshevoi S, Guris D, Emiroglu N.

J Infect Dis. 2003 May 15;187 Suppl 1:S191-7. Review.

PMID:
12721913
18.

Measles.

Arguedas AG, Deveikis AA, Marks MI.

Am J Infect Control. 1991 Dec;19(6):290-8. Review.

PMID:
1763825
19.

[Vaccinations: the necessary and the desirable].

Matter L.

Schweiz Med Wochenschr. 1997 Mar 8;127(10):377-81. Review. German.

PMID:
9132924
20.

[The significance of epidemiological studies for progress of measles elimination].

Mrozek-Budzyn D.

Przegl Epidemiol. 2010;64(3):361-6. Review. Polish.

PMID:
20976947

Supplemental Content

Support Center